Last $1.56 USD
Change Today +0.0932 / 6.34%
Volume 4.2K
ESMC On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

escalon medical corp (ESMC) Key Developments

Escalon Medical Corp. Reports Consolidated Earnings Results for the First Quarter Ended September 30, 2014

Escalon Medical Corp. reported consolidated earnings results for the first quarter ended September 30, 2014. For the quarter, the company reported a net loss of $458,959 and a net loss from continuing operations of $440,196, or $0.06 per share. This compares to net income of $13,241 for the first quarter of fiscal 2014 and net income from continuing operations of $38,846. Revenues, net were $2,630,320 against $3,130,083 for the same period a year ago. Loss from operations was $440,235 against profit from operations of $37,717 for the same period a year ago. Loss from continuing operations was $440,196 or $0.06 per basic and diluted share against income from continuing operations of $38,846 or $0.00 per basic and diluted share for the same period a year ago.

Escalon Medical Corp., Annual General Meeting, Dec 23, 2014

Escalon Medical Corp., Annual General Meeting, Dec 23, 2014., at 09:00 US Eastern Standard Time. Location: 435 Devon Park Drive, Building 100. Agenda: To elect two class III directors, each for a term of three years and until their respective successors have been elected to serve; to ratify the selection of Mayer Hoffman McCann P.C. as the company's independent registered public accounting firm for the fiscal year ending June 30, 2015; and to discuss any other matters that properly come before annual meeting.

Escalon Medical Corp. Reports Un-Audited Consolidated Earnings Results for the Year Ended June 30, 2014

Escalon Medical Corp. reported un-audited consolidated earnings results for the year ended June 30, 2014. For the year, the company reported a net loss of $381,883 or $0.05 per share and a net loss from continuing operations of $349,532, or $0.05 per share. This compares to net income of $2.6 million, or $0.35 per share, for fiscal 2013, which includes a net gain of $3.9 million related to the sale of Drew and related debt settlement. The net loss from continuing operations was $1.2 million, or $0.16 per share, for fiscal 2013. The company reported revenue, net of $12.4 million compared to $11.5 million and loss from operations of $0.4 million compared to $1.2 million for the last year.

Escalon Medical Corp. Announces Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Escalon Medical Corp. announced earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company reported net income was $86,084, or $0.01 per share, compared to a net loss of $285,864, or $0.04 loss per share, for the same quarter ended March 31, 2013. Net revenues for the third quarter ended March 31, 2014 were $3.15 million, compared to $2.72 million for the same quarter ended March 31, 2013. Net loss for the nine months ended March 31, 2014 was $9,223, or $0 per share, compared to a net income of $3.27 million, or $0.44 per share, for the same period ended March 31, 2013. Net revenues for the nine months ended March 31, 2014 were $9.36 million, compared to $8.63 million for the same period ended March 31, 2013.

Escalon Medical Corp. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Escalon Medical Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company's revenues, net was $3,151,651 against $2,724,740 a year ago. Income from operations was $112,308 against loss from operations of $294,865 a year ago. Net income from continuing operations was $112,354 or $0.01 per basic and diluted share against net loss from continuing operations of $283,761 or $0.04 per basic and diluted share a year ago. Net income was $86,084 or $0.01 per basic and diluted share against net loss of $285,864 or $0.04 per basic and diluted share a year ago. For the nine months, the company's revenues, net was $9,360,219 against $8,635,078 a year ago. Income from operations was $60,719 against loss from operations of $781,847 a year ago. Net income from continuing operations was $68,426 or $0.01 per basic and diluted share against net loss from continuing operations of $781,424 or $0.10 per basic and diluted share a year ago. Net income was $9,223 against net income of $3,274,082 or $0.44 per basic and diluted share a year ago, which includes a net gain of $4.1 million related to the sale of Drew and related debt settlement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESMC:US $1.56 USD +0.0932

ESMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ESMC.
View Industry Companies
 

Industry Analysis

ESMC

Industry Average

Valuation ESMC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 3.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESCALON MEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.